Close Menu

NEW YORK – Genome-wide polygenic risk scores are more predictive of coronary heart disease in three US racial or ethnic groups than restricted polygenic risk scores, a new study has found. 

Scores of genetic loci have been linked to the risk of developing coronary heart disease (CHD), and researchers have used these to generate polygenic risk scores to predict coronary events. But as these scores largely have been developed in cohorts of European ancestry, their utility among other ancestry groups has not been clear.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.